Recent Articles
Lululemon’s EPS Expected to Climb: What LULU Stock Owners Should Know Ahead of Next Week’s Release
By
LULU possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Owners and prospective buyers of LULU stock should examine these factors.
Facebook, Apple, Amazon, or Netflix: Time to Buy a Few FAANG Stocks Again?
By
Should investors consider buying some FAANG stocks, such as Netflix stock, Facebook, Apple or Amazon?
ULTA Reporting After the Bell Today: Will ULTA Stock Remain a Retail Jewel?
By
ULTA stock has had some strong, positive catalysts, including ULTA's ability to meet the needs of its younger customers.
Nike Stock Is Outpacing the Market: What You Should Know
By
Nike stock closed yesterday at $83.48, gaining 1.77% from the previous trading session. NKE stock is also outpacing the market in early trading today.
Amgen to Buy Celgene’s Otezla for $13.4B: Is the Deal Good for Amgen Stock?
By
Amgen's purchase of Celgenes blockbuster psoriasis drug, Otezla is likely to strengthen its position in the immunology space and boost Amgen stock.

Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.